Inhibition of adhesion, invasion, and metastasis by antibodies targeting CEACAM6 (NCA-90) and CEACAM5 (carcinoembryonic antigen)

Cancer Research

Volumn 65, Issue 19, 2005, Pages 8809-8817

  Blumenthal, Rosalyn D ^a,c   Hansen, Hans J ^b   Goldenberg, David M ^a  

^a CENTER FOR MOLECULAR MEDICINE AND IMMUNOLOGY   (United States)

^b IMMUNOMEDICS INC   (United States)

^c GARDEN STATE CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CARCINOEMBRYONIC ANTIBODY; CARCINOEMBRYONIC ANTIGEN RELATED CELL ADHESION MOLECULE 1; CARCINOEMBRYONIC ANTIGEN RELATED CELL ADHESION MOLECULE 5; CARCINOEMBRYONIC ANTIGEN RELATED CELL ADHESION MOLECULE 6; COLLAGEN TYPE 1; COLLAGEN TYPE 4; EPITOPE; IMMUNOGLOBULIN F(AB) FRAGMENT; LABETUZUMAB; LAMININ; MONOCLONAL ANTIBODY MN 14; MONOCLONAL ANTIBODY MN 15; MONOCLONAL ANTIBODY MN 3; UNCLASSIFIED DRUG; VITRONECTIN;

ADOLESCENT; AMINO TERMINAL SEQUENCE; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BREAST CANCER; CANCER CELL CULTURE; CANCER INVASION; CANCER SURVIVAL; CELL ADHESION; CELL MIGRATION; COLON CANCER; CONTROLLED STUDY; DRUG EFFICACY; EXTRACELLULAR MATRIX; FEMALE; GENE OVEREXPRESSION; HUMAN; HUMAN CELL; IN VITRO STUDY; LUNG CANCER; METASTASIS; MOUSE; NONHUMAN; PANCREAS CANCER; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN EXPRESSION;

ANIMALS; ANTIBODIES; ANTIGENS, CD; CARCINOEMBRYONIC ANTIGEN; CELL ADHESION; CELL ADHESION MOLECULES; CELL LINE, TUMOR; CELL MOVEMENT; COLONIC NEOPLASMS; ENDOTHELIAL CELLS; FEMALE; HUMANS; LUNG NEOPLASMS; MICE; MICE, NUDE; NEOPLASM INVASIVENESS; NEOPLASM METASTASIS; NEOPLASMS; XENOGRAFT MODEL ANTITUMOR ASSAYS;

EID: 25444482609     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: 10.1158/0008-5472.CAN-05-0420     Document Type: Article

References (58)

1. Fidler IJ. Critical factors in the biology of human cancer metastasis: twenty- eighth G.H.A. Clowes memorial award lecture. Cancer Res 1990;50;6130-8.
2. Goldenberg DM, Sharkey RM, Primus FJ. Carcinoembryonic antigen in histopathology: immunoperoxidase staining of conventional tissue sections. J Natl Cancer Inst 1976;57:11-22.
3. Shively JE, Beatty JD. CEA-related antigens: molecular biology and clinical significance. Crit Rev Oncol Hematol 1985;2:355-99.
4. Thompson JA, Grunert F, Zimmermann W. Carcinoembryonic antigen gene family: molecular biology and clinical perspectives. J Clin Lab Anal 1991;5:344-66.
5. Gold P, Goldenberg NA, The carcinoembryonic antigen (CEA): past present, and future. McGill J Med 1997;3:46-66.
6. Hammarstrom S. The carcinoembryonic antigen (CEA) family: structures, suggested functions and expression in normal and malignant tissues. Semin Cancer Biol 1999;9:67-81.
7. Jessup JM, Thomas P. CEA and metastasis: a facilitator of site-specific metastasis. In: Stanners CP, editor. Cell adhesion and communication by the CEA family. Vol. 5. Amsterdam: Harwood Academic Publishers; 1998. p. 195-222.
8. Yoshioka T, Masuko T, Kotanagi H, et al. Homotypic adhesion through carcinoembryonic antigen plays a role in hepatic metastasis development. Jpn J Cancer Res 1998;89:177-85.
9. Hashino J, Fukuda Y, Oikawa S, Nakazato H, Nakanishi T. Metastatic potential of human colorectal carcinoma SW1222 cells transfected with cDNA encoding carcinoembryonic antigen. Clin Exp Metastasis 1994;12:324-8.
10. Kim JC, Koo KH, Kim BS, Park KC, Bicknell DC, Bodmer WF. Carcino-embryonic antigen may function as a chemoattractant in colorectal carcinoma cell lines. Int J Cancer 1999;82:880-5.
11. Minami S, Furui J, Kanematsu T. Role of carcinoembryonic antigen in the progression of colon cancer cells that express carbohydrate antigen. Cancer Res 2001;61:2732-5.
12. Benchimol S, Fuks A, Jothy S, Beauchemin N, Shirota K, Stanners CP. Carcinoembryonic antigen, a human tumor marker, functions as a intercellular adhesion molecule. Cell 1989;57:327-34.
13. Oikawa S, Inuzuka C, Kuroki M, Matsuoka Y, Kosaki G, Nakazato H. Cell adhesion activity of non-specific cross-reacting antigen (NCA) and carcinoembryonic antigen (CEA) expressed on CHO cell surface: homophilic and heterophilic adhesion. Biochem Biophys Res Commun 1989;164:39-45.
14. Stanners CP, Fuks A. Properties of adhesion mediated by the human CEA family. In: Stanners CP, editor. Cell adhesion and communication by the CEA family. Vol. 5. Amsterdam: Harwood Academic Publishers; 1998. p. 57-72.
15. Wirth T, Soeth E, Czubayko F, Juhl H. Inhibition of endogenous carcinoembryonic antigen (CEA) increases the apoptotic rate of colon cancer cells and inhibits metastatic tumor growth. Clin Exp Metastasis 2002;19:155-60.
16. Blumenthal RD, Osorio L, Hayes MK, Horak ID, Hansen HJ, Goldenberg DM. Carcinoembryonic antigen antibody inhibits metastasis and augments chemotherapy in a human colonic carcinoma xenograft. Cancer Immuno Immunother 2005;54:315-27.
17. Stein R, Goldenberg DM. A humanized monoclonal antibody to carcinoembryonic antigen, labetuzumab, inhibits tumor growth and sensitizes human medullary thyroid cancer xenografts to decarbazine chemotherapy. Mol Cancer Ther 2005;3:1559-64.
18. Kuroki M, Matsuo Y, Kinugasa T, Matsuoka Y. Three different NCA species, CGM6/CD67, NCA-95, and NCA-90 are comprised in the major 90 to 100 kDa band of granulocyte NCA detectable upon SDS-polyacrylamide gel electrophoresis. Biochem Biophys Res Commun 1992;182:501-6.
19. Scholzel S, Zimmermann W, Schwarzkopf G, Grunert F, Rogaczewski B, Thompson J. Carcinoembryonic antigen family members CEACAM6 and CEACAM7 are differentially expressed in normal tissues and oppositely deregulated in hyperplastic colorectal polyps and early adenomas. Am J Pathol 2000;157:1051-2.
20. Hinoda Y, Saito T, Takahashi H, Itoh F, Adachi M, Imai K. Induction of nonspecific cross-reacting antigen mRNA by interferon-γ and anti-fibronectin receptor antibody in colon cancer cells. J Gastroenterol 1997;32:200-5.
21. Kuroki M, Matsushita H, Matsumoto H, Hirose Y, Senba T, Ymamoto T. Nonspecific cross-reacting antigen 50/90 (NCA-50/90) as a new tumor marker. Anticancer Res 1999;19:5599-606.
22. Ilantzis C, DeMarte L, Screaton RA, Stanners CP. Deregulated expression of the human marker CEA and CEA family member CEACAM6 disrupts tissue architecture and blocks coloncyte differentiation. Neoplasia 2002;4:151-63.
23. Jantscheff P, Terracciano L, Lowy A, et al. Expression of CEACAM6 in resectable colorectal cancer: a factor of independent prognostic significance. J Clin Oncol 2003;21:3638-46.
24. Kuijpers TW, Hoogerwerf M, van der Laan IJ, et al. CD66 nonspecific cross-reacting antigens are involved in neutrophil adherence to cytokine-activated endothelial cells. J Cell Biol 1992;118:457-66.
25. Yamanka T, Kuroki M, Matsuo Y, Matsuoka Y. Analysis of heterophilic cell adhesion mediated by CD66b and CD66c using their soluble recombinant proteins. Biochem Biophys Res Commun 1996;219:842-7.
26. Frisch SM, Francis H. Disruption of epithelial cell-matrix interactions induces apoptosis. J Cell Biol 1994;124:616-26.
27. Ordonez C, Screaton RA, Ilantzis C, Stanners CP. Human carcinoembryonic antigen functions as a general inhibitor of anoikis. Cancer Res 2000;60:3419-24.
28. Duxbury MS, Ito H, Zinner MJ, Ashley SW, Whang EE. CEACAM6 gene silencing impairs anoikis resistance and in vivo metastatic ability of pancreatic adenocarcinoma cells. Oncogene 2004;23:465-73.
29. Duxbury MS, Ito H, Benoit E, Zinner MJ, Ashley SW, Whang EE. Overexpression of CEACAM6 promotes insulin-like growth factor I-induced pancreatic adenocarcinoma cellular invasiveness. Oncogene 2004.
30. Duxbury MS, Ito H, Benoit E, Waseem T, Ashley SW. Whang EE. A novel role for carcinoembryonic antigen-related cell adhesion molecule 6 as a determinant of gemcitabine chemoresistance in pancreatic adenocarcinoma cells. Cancer Res 2004;64:3987-93.
31. Duxbury MS, Ito H, Benoit E, Ashley SW Whang EE. CEACAM6 is a determinant of pancreatic adenocarcinoma cellular invasiveness. Br J Cancer 2004;91:1384-90.
32. Audette M, Buchegger F, Schreyer M, Mach JP. Monoclonal antibody against carcinoembryonic antigen (CEA) identifies two new forms of crossreacting antigens of molecular weight 90,000 and 160,000 in normal granulocytes. Mol Immunol 1987;24:1177-86.
33. Bjerner J, Lebedin Y, Bellanger L, et al. Protein epitopes in carcinoembryonic antigen. Tumour Biol 2002;23:249-62.
34. Taheri M, Saragovi U, Fuks A, Makkerh J, Mort J, Stanners CP. Self recognition in the Ig superfamily. J Biol Chem 2000;275:26935-43.
35. Taheri M, Saragovi HU, Stanners CP. The adhesive and differentiation- inhibitory activities of the immunoglobulin superfamily member, carcinoembryonic antigen, can be independently blocked. J Biol Chem 2003;278:14632-9.
36. Jessup JM, Kim JC, Thomas P, et al. Adhesion to carcinoembryonic antigen by human colorectal carcinoma cells involves at least two epitopes. Int J Cancer 1993;55:262-8.
37. Sharkey RM, Juweid M, Shevitz J, et al. Evaluation of a complementarity-determining region-grafted (humanized) anti-carcinoembryonic antigen monoclonal antibody in preclinical and clinical studies. Cancer Res 1995;55:5935-45.
38. Hazan RB, Phillips GR, Qiao RF, Norton L, Aaronson SA, Expgenous expression of N-cadherin in breast cancer cells induces cell migration, invasion, and metastasis. J Cell Biol 2000;148:779-90.
39. Tantivejkul K, Vucenik I, Shamsuddin AM. Inositol hexaphosphate (IP6) inhibits key events of cancer metastasis: 1. In vitro studies of adhesion, migration and invasion of MDA-MB231 human breast cancer cells. Anticancer Res 2003;23:3671-9.
40. Sharkey RM, Weadock KS, Natale A, et al. Successful radioimmunotherapy for lung metastasis of human colonic cancer in nude mice. J Natl Cancer Inst 1991;83:627-32.
41. 1311-labeled monoclonal antibodies. Cancer Res 1992;52:6036-44.
42. Goldenberg D, Witte S, Elster K. GW-39: a new human tumor serially transplantable in the golden hamster. Transplantation 1966;4:760-4.
43. Borden E, Esserman L, Linder D, Campbell M, Fulton A. Biological therapies for breast carcinoma: concepts for improvement in survival. Semin Oncol 1999;26:28-40.
44. Sliwkowski M, Lofgren J, Lewis G, Hotaling T, Fendly B, Fox J. Nonclinical studies addressing the mechanism of action of trastuzumab (Herceptin). Semin Oncol 1999;26:60-70.
45. Bodey B, Siegel S, Kaiser H. Human cancer detection and immunotherapy with conjugated and non-conjugated monoclonal antibodies. Anticancer Res 1996;16:661-74.
46. Riethmuller G, Schneider-Gadicke E, Schlimok G, et al. The, German Cancer Aid 17-1A Study Group. Randomized trial of monoclonal antibody for adjuvant therapy of resected Dukes' C colorectal carcinoma. Lancet 1994;343;1177-83.
47. Weiner L, Adams G. New approaches to antibody therapy. Oncogene 2000;19:6144-51.
48. Alas S, Bonavida B. Rituximab inactivates signal transducer and activation of transcription 3 (STAT3) activity in B-non-Hodgkin's lymphoma through inhibition of the interleukin 10 autocrine/paracrine loop and results in down regulation of bcl-2 and sensitization to cytotoxic drugs. Cancer Res 2001;61:5137-44.
49. Duxbury MS, Ito H, Ashley SW, Whang EE. CEACAM6 cross-linking induces caveolin-1-dependent, Src-mediated focal adhesion kinase phosphorylation in BxPC3 pancreatic adenocarcinoma cells. J Biol Chem 2004;279:23176-82.
50. Gangopadhyay A, Lazerus DA, Thomas P. Adhesion of colorectal carcinoma cells to the nedothelium is mediated by cytokines from CEA stimulated Kupffer cells. Clin Exp Metastasis 1998;16:703-12.
51. Van der Velde-Zimmermann D, Verdaasdonk MA, Rademakers LH, De Weger RA, Van den Tweel JG, Joling P. Fibronectin distribution in human bone marrow stroma: matrix assembly and tumor cell adhesion via α5 β1 integrin. Exp Cell Res 1997;230:111-20.
52. Matsumoto Y, Saiki I, Makabe T, et al. Inhibitory effect of antimetastatic fusion polypeptide of human fibronectin on tumor cell adhesion to extracellular matrices. Jpn J Cancer Res 1991;82:1130-8.
53. Islam SM, Whalen GF, Sharif SF. Inhibition of tumor cell adhesion to lymph nodes by laminin-related peptide and neuraminidase. Surgery 1993;113:676-82.
54. Chen J, Thompson LU. Lignans and tamoxifen, alone or in combinations, reduce human breast cancer cell adhesion, invasion and migration in vitro. Breast Cancer Res Treat 2003;80:163-70.
55. Zeng G, Gao L, Yu RK. Reduced cell migration, tumor growth and experimental metastasis of rat F-11 cells whose expression of GD3-synthase is suppressed. Int J Cancer 2000;88:53-7.
56. Jadeski LC, Hum KO, Chakraborty C, Lala PK. Nitric oxide promotes murine mammary tumour growth and metastasis by stimulating tumour cell migration, invasiveness and angiogenesis. Int J Cancer 2000;86:30-9.
57. Grunert F, Daniel S, Nagel G, von Kleist S, Jantscheff P. CD66b, CD66c and carcinoembryonic antigen (CEA) are independently regulated markers in sera of tumor patients. Int J Cancer 1995;63:349-55.
58. Duxbury MS, Ito H, Ashley SW Whang EE. CEACAM6 as a novel target for indirect type 1 immunotoxin-based therapy in pancreatic adenocarcinoma. Biochem Biophys Res Commun 2004;317:837-43.